KDR and neoplasm: Our flow cytometry results revealed that VEGFR-2 is present on the cell surface of NSCLC tumor cells and IHC results showed expression in the cytoplasm and nuclear compartments of NSCLC patients’ cells (Figure 3 and Figure 8) [55,56].